Molecular insights of the G2019S substitution in LRRK2 kinase domain associated with Parkinson's disease: A molecular dynamics simulation approach

被引:30
|
作者
Agrahari, Ashish Kumar [1 ]
Doss, George Priya C. [1 ]
Siva, R. [1 ]
Magesh, R. [2 ]
Zayed, Hatem [3 ]
机构
[1] VIT, Sch Biosci & Technol, Dept Integrat Biol, Vellore 632014, Tamil Nadu, India
[2] DU, SRIHER, Dept Biotechnol, Chennai 600116, Tamil Nadu, India
[3] Qatar Univ, Coll Hlth & Sci, Dept Biomed Sci, Doha, Qatar
关键词
PD; LRRK2; Kinase domain; G2019S; DYG; Molecular dynamics simulation; MUTATIONAL ANALYSIS; PROTEIN; IMPACT; MECHANISMS; GENE; GTPASE; MODEL;
D O I
10.1016/j.jtbi.2019.03.003
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The G2019S substitution in the Leucine-rich repeat kinase 2 (LRRK2) is significantly associated with Parkinson's disease (PD). This substitution was identified in both familial and sporadic forms of PD with a higher frequency. Few computational studies have reported the impact of G2019S substitution on inhibitors of the kinase domain of LRRK2. However, no computational study deeply investigated the possible impact of the G2019S substitution on the kinase domain in its Apo conformation. Therefore, in this study, we used 200 ns molecular dynamic simulation using the GROMACS 5.1.4 package software to investigate the impact of the G2019S substitution on the structure of the kinase domain of LRRK2. Our results indicate that the G2019S substitution affects the dynamics and stability of LRRK2 by decreasing the flexibility and increasing the compactness of the kinase domain and showing its tendency to be in an active conformation for long time interval because of the high energy barrier between active and inactive conformation. This study predicts the molecular pathogenicity mechanism of the G2019S on patients with PD and provides a potential platform for developing therapeutics for patients with PD that harbor this amino acid substitution. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 50 条
  • [21] Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers
    Fraser, Kyle B.
    Moehle, Mark S.
    Alcalay, Roy N.
    West, Andrew B.
    NEUROLOGY, 2016, 86 (11) : 994 - 999
  • [22] The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation : AAssociation with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel
    Hassin-Baer S.
    Laitman Y.
    Azizi E.
    Molchadski I.
    Galore-Haskel G.
    Barak F.
    Cohen O.S.
    Friedman E.
    Journal of Neurology, 2009, 256 (3) : 483 - 487
  • [23] Differential Phospho-Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease
    Garrido, Alicia
    Santamaria, Enrique
    Fernandez-Irigoyen, Joaquin
    Soto, Marta
    Simonet, Cristina
    Fernandez, Manel
    Obiang, Donina
    Tolosa, Eduardo
    Marti, Maria-Jose
    Padmanabhan, Shalini
    Malagelada, Cristina
    Ezquerra, Mario
    Fernandez-Santiago, Ruben
    MOVEMENT DISORDERS, 2022, 37 (05) : 1004 - 1015
  • [24] Clinical Expression of LRRK2 G2019S Mutations in the Elderly
    San Luciano, Marta
    Lipton, Richard B.
    Wang, Cuiling
    Katz, Mindy
    Zimmerman, Molly E.
    Sanders, Amy E.
    Ozelius, Laurie J.
    Bressman, Susan B.
    Saunders-Pullman, Rachel
    MOVEMENT DISORDERS, 2010, 25 (15) : 2571 - 2576
  • [25] Rab29 activation of the Parkinson's disease-associated LRRK2 kinase
    Purlyte, Elena
    Dhekne, Herschel S.
    Sarhan, Adil R.
    Gomez, Rachel
    Lis, Pawel
    Wightman, Melanie
    Martinez, Terina N.
    Tonelli, Francesca
    Pfeffer, Suzanne R.
    Alessi, Dario R.
    EMBO JOURNAL, 2018, 37 (01) : 1 - 18
  • [26] The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease
    Greenbaum, Lior
    Israeli-Korn, Simon D.
    Cohen, Oren S.
    Elincx-Benizri, Sandra
    Yahalom, Gilad
    Kozlova, Evgenia
    Strauss, Hanna
    Molshatzki, Noa
    Inzelberg, Rivka
    Spiegelmann, Roberto
    Israel, Zvi
    Hassin-Baer, Sharon
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (11) : 1053 - 1056
  • [27] Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene
    Hatteland Somme, Johanne
    Molano Salazar, Ana
    Gonzalez, Amaia
    Tijero, Beatriz
    Berganzo, Koldo
    Lezcano, Elena
    Fernandez Martinez, Manuel
    Jose Zarranz, Juan
    Carlos Gomez-Esteban, Juan
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (05) : 494 - 499
  • [28] Roc, the G-domain of the Parkinson's disease-associated protein LRRK2
    Park, Yangshin
    Liao, Jingling
    Hoang, Quyen Q.
    TRENDS IN BIOCHEMICAL SCIENCES, 2022, 47 (12) : 1038 - 1047
  • [29] G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain
    An Phu Tran Nguyen
    Daniel, Guillaume
    Valdes, Pamela
    Islam, Md Shariful
    Schneider, Bernard L.
    Moore, Darren J.
    HUMAN MOLECULAR GENETICS, 2018, 27 (01) : 120 - 134
  • [30] Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment
    Gomez, Anna
    Ferrer, Isidre
    ACTA NEUROPATHOLOGICA, 2010, 120 (02) : 155 - 167